Replies to post #13529 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>$30M for sales-based milestones (commercial sales are ongoing so these milestones could kick in).<

The $30M in sales-based milestones from Leo will not be triggered until ATryn is approved for an indication other than HD.